November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 13, 2026
Pet Therapeutic Diet Market (By Pet Type: Dogs, Cats, Other; By Indication: Digestive Health, Renal Health,Weight Management, Diabetes Care, Cardiac Health,Allergy & Skin Care, Joint & Mobility Support, Liver Health; By Product Type: Dry Food, Wet Food, Snacks & Treats, Supplements; By Distribution Channel: Veterinary Cli...
April 13, 2026
Genitourinary Drugs Market (By Indication: Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Haematuria, Benign Prostatic Hyperplasia; By Product: Urologicals, Hormonal Th...
April 13, 2026
Peptide Therapeutics Market(By Type: Branded Peptide Drugs, Generic Peptide Drugs, By Route of Administration: Parenteral, Oral, Transdermal & Others, By Application/Therapeutic: Area Oncology, Metabolic Disorders, Infectious Diseases, Cardiovascular Disorders, Neurological Disorders, Others; By Synthesis Technology: Solid Phase Peptide Synt...
April 10, 2026
According to our projections, the digital therapeutics for mental health market was valued at USD 3.74 billion in 2025 and is expected to reach USD 4.51 billion in 2026, expanding rapidly to approximately USD 24.42 billion by 2035, registering a strong CAGR of 20.64% from 2026 to 2035....
April 10, 2026
According to our projections, the mental health treatment market was valued at USD 66.78 billion in 2025 and is expected to grow from USD 71.22 billion in 2026 to USD 127.13 billion by 2035, registering a CAGR of 6.65%. The report provides a comprehensive assessment of market size, historical and forecast data, detailed segmentation...
April 10, 2026
Brachytherapy Market ( By Type: High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy, Pulse-Dose Rate (PDR) Brachytherapy; By Application: Prostate Cancer, Gynecological Cancers, Breast Cancer, Skin Cancer, Head & Neck Cancer, Others; By End User: Hospitals, Cancer Treatment & Radiotherapy Centers, Academic & Research I...
April 10, 2026
Intravenous Immunoglobulin Market ( By Indication: Primary Immunodeficiency Diseases (PID), Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenia (ITP), Kawasaki Disease, Multifocal Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Others (Lupus, Dermatomyositis, Off-label uses); By Concent...
April 10, 2026
Veterinarian Care Market ( By Service Type: Preventive & Wellness Care, Surgery & Emergency Care, Specialty Services, Rehabilitation & Physical Therapy; By Animal Type: Companion Animals, Livestock Animals, Equine; By End User: Private Veterinary Clinics, Veterinary Hospitals, Mobile Veterinary Services, Academic & Research Institut...
April 09, 2026
U.S. Sex Reassignment Hormone Therapy Market (By Hormone Type: Estrogen, Testosterone, Anti-androgens; By Gender Category: Male-to-Female (MTF), Female-to-Male (FTM); By Route of Administration: Oral, Injectable; By Distribution Channel: Hospitals, Clinics, Transdermal (Patch), Sublingual; By End User: Hospitals, Clinics, Home Care, Others; Country...
April 09, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, Ophthalmology, Pain Management, Urology, Immunology, Hematology, Rare Diseases; By Drug Type: Br...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com